REN Haifeng, ZHAO Yingkui, YANG Feng, YU Yuan, MA Zhiqiang. Study on synthesis and cyto-toxicity of polyethylene glycol-b-polylysine as potencial miRNA carrier[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 362-365,373. doi: 10.3969/j.issn.1006-0111.2014.05.013
| Citation:
|
REN Haifeng, ZHAO Yingkui, YANG Feng, YU Yuan, MA Zhiqiang. Study on synthesis and cyto-toxicity of polyethylene glycol-b-polylysine as potencial miRNA carrier[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 362-365,373. doi: 10.3969/j.issn.1006-0111.2014.05.013
|
Study on synthesis and cyto-toxicity of polyethylene glycol-b-polylysine as potencial miRNA carrier
- Received Date: 2014-02-21
- Rev Recd Date:
2014-06-28
-
Abstract
Objective To synthesize miRNA carrier PEG-b-PLL and to testify the stability, encapsulation efficiency and cytotoxicity of its complexes. Methods H1NMR was used to determine the degree of polymerization of PLL, 4% agarose gel electrophoresis was used to determine entrapment of the polyer to the miRNA; then dynamic light scattering(DLS) was used to measure the hydrodynamic parameter such as size, polydispersity index(PDI) and zeta potential of the polyplexes. The entrapment efficiency was determined by ultraviolet-visible spectrophotometer, and finally, the cyto-toxicity of PEG-b-PLL was evaluated by CKK-8 kit with K562 cell lines. Results The characteristics indicated polyplexes prepared by PEG-b-PLL and miRNA fulfill the demand of being the gene carrier of miRNA because of low cyto-toxicity, high encapsulation efficiency and stability. Conclusion The miRNA carrier PEG-b-PLL had good character and low cyto-toxicity. It showed considerable potential as an efficient miRNA carrier.
-
References
|
[1]
|
Lee RC, Feinbaum RL, Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J].Cell, 1993, 75(5):843-854. |
|
[2]
|
Hagiwara K, Ochiya T, Kosaka N. A paradigm shift for extracellular vesicles as small RNA carriers:from cellular waste elimination to therapeutic applications[J].Drug Deliv Transl Res, 2014, 4:31-37. |
|
[3]
|
Sheherbata HR,Hatfield S,Ward EJ,et al.The MicroRNA pathway plays a regulatory role in stem cell division[J].Cell Cycle, 2006, 5(2):172-175. |
|
[4]
|
Hatfield SD, Sheherbata HR, Fischer KA, et al. Stem cell division is regulated by the microRNA pathway[J].Nature, 2005, 435(7044):974-978. |
|
[5]
|
Tan PH, Pao YY, Cheng JK, et al. MicroRNA-based therapy in pain medicine:current progress and future prospects[J].Acta Anaesthesiol Taiwanica, 2013, 51:171-176. |
|
[6]
|
Hatakeyama H, Murata M, Sato Y, et al. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice[J].J Control Rel, 2014, 173:43-50. |
|
[7]
|
Marshall E. Gene therapy death prompts review of adenovirus vector[J].Science, 1999, 286:2244-2245. |
|
[8]
|
Hollon T. Researchers and regulators reflect on first gene therapy death[J].Am J Ophthalmol, 2000, 129(5):701. |
|
[9]
|
Assessment of adenoviral vector safety and toxicity:report of the National Institutes of Health Recombinant DNA Advisory Committee [J].Hum Gene Ther, 2002, 13(1):3-13. |
|
[10]
|
Cavazzana Calvo M, Hacein Bey S, Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease[J].Science, 2000, 288:669-672. |
|
[11]
|
Sanjoh M, Miyata K, Christie RJ, et al. Dual environment-responsive polyplex carriers for enhanced intracellulardelivery of plasmid DNA[J].Biomacromolecules, 2012, 13(11):3641-3649. |
|
[12]
|
Osada K, Shiotani T, Tockary TA, et al. Enhanced gene expression promoted by the quantized folding of pDNA within polyplex micelles[J].Biomaterials, 2012, 33(1):325-332. |
|
[13]
|
Sanjoh M, Hiki S, Lee Y, et al. pDNA/poly(L-lysine) polyplexes functionalized with a pH-sensitive charge-conversional poly(aspartamide) derivative for controlled gene delivery to human umbilical vein endothelial cells[J]. Macromol Rapid Commun. 2010, 31(13):1181-1186. |
-
-
Proportional views
-
DownLoad: